Vistagen Announces Completion of Last Patient Visit in PALISADE-4 Phase 3 Public Speaking Challenge Study of Fasedienol for Acute Treatment of Social Anxiety Disorder

anxiety

Vistagen Announces Completion of Last Patient Visit in PALISADE-4 Phase 3 Public Speaking Challenge Study of Fasedienol for Acute Treatment of Social Anxiety Disorder

ONLY AVAILABLE IN PAID PLANS.

Originally reported by biospace. Read more

Source: https://www.biospace.com/press-releases/vistagen-announces-completion-of-last-patient-visit-in-palisade-4-phase-3-public-speaking-challenge-study-of-fasedienol-for-acute-treatment-of-social-anxiety-disorder